Mullerian-inhibiting substance regulates NF–κB signaling in the prostate <i>in vitro</i> and <i>in vivo</i>

Dorry L. Segev(Johns Hopkins University), Shyamala Maheswaran(Massachusetts General Hospital), Yasunori Hoshiya(Massachusetts General Hospital), Jennifer Carey(Harvard University), Makiko Hoshiya(Massachusetts General Hospital), Antonia E. Stephen(Harvard University), Patricia K. Donahoe(Harvard University), Trinh T. Tran(Harvard University), David T. MacLaughlin(Harvard University)
Proceedings of the National Academy of Sciences
January 2, 2002
10.1073/pnas.221599298
Cited by 72

Related Papers

Isolation of rare circulating tumour cells in cancer patients by microchip technology
|Nature|2007|3.5k
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
|Cell|2010|2.8k
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
|Cell|2014|2.5k
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
|Science|2013|2.5k
Isolation of circulating tumor cells using a microvortex-generating herringbone-chip
|Proceedings of the National Academy of Sciences|2010|1.6k